Search all trials

Find therapies in clinical trials near you – page 86

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Hepatocellular carcinoma

Not recruiting

Registered drug

Study of Pembrolizumab as Additional Treatment for Patients with Liver Cancer (Hepatocellular Carcinoma) After Surgery or Local Ablation

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Cardiovascular disorder

Not recruiting

Registered drug

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Cardiac failure+1

Not recruiting

Investigational

Study of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Azd3427

Contact Research Centre

Bladder cancer

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab, Vibostolimab, and Favezelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to BCG Therapy

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Dry age-related macular degeneration

Not recruiting

Registered drug

Study on JNJ-81201887 for Treating Geographic Atrophy in Age-related Macular Degeneration Patients

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Prednisone

Contact Research Centre

COVID-19

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients

Registered drug

Sweden

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nirmatrelvir

Contact Research Centre

Endometrial cancer

Not recruiting

Registered drug

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Loperamide

Contact Research Centre

Generalised anxiety disorder

Not recruiting

Investigational

Study on the Effectiveness and Safety of Ulotaront for Adults with Generalized Anxiety Disorder

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Ulotaront

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Registered drugNo placebo

Sweden

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Prostate cancer recurrent

Not recruiting

Registered drug

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Darolutamide

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

Registered drugNo placebo

Study on Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes Needing Blood Transfusions

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Epoetin Alfa

Contact Research Centre

Transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study on Reduced BCG Dwell-Time for Patients with High-Risk Urothelial Cancer

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years

Contact Research Centre

Find therapies in clinical trials near you – page 86

1 071 trials match your criteria

Hepatocellular carcinoma

Study of Pembrolizumab as Additional Treatment for Patients with Liver Cancer (Hepatocellular Carcinoma) After Surgery or Local Ablation

Cardiovascular disorder

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Cardiac failure+1

Study of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease

Bladder cancer

Study of Pembrolizumab, Vibostolimab, and Favezelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to BCG Therapy

Dry age-related macular degeneration

Study on JNJ-81201887 for Treating Geographic Atrophy in Age-related Macular Degeneration Patients

COVID-19

Study on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients

Endometrial cancer

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Generalised anxiety disorder

Study on the Effectiveness and Safety of Ulotaront for Adults with Generalized Anxiety Disorder

Malignant melanoma

Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

Prostate cancer recurrent

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Myelodysplastic syndrome

Study on Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes Needing Blood Transfusions

Transitional cell carcinoma

Study on Reduced BCG Dwell-Time for Patients with High-Risk Urothelial Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.